ATE297715T1 - Teilchen - Google Patents

Teilchen

Info

Publication number
ATE297715T1
ATE297715T1 AT98949090T AT98949090T ATE297715T1 AT E297715 T1 ATE297715 T1 AT E297715T1 AT 98949090 T AT98949090 T AT 98949090T AT 98949090 T AT98949090 T AT 98949090T AT E297715 T1 ATE297715 T1 AT E297715T1
Authority
AT
Austria
Prior art keywords
targeted
particle
cell
particles
permeability
Prior art date
Application number
AT98949090T
Other languages
English (en)
Inventor
David John Clarke
Michael Henry Harrison
Harmesh Singh Aojula
Original Assignee
Univ Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Manchester filed Critical Univ Manchester
Application granted granted Critical
Publication of ATE297715T1 publication Critical patent/ATE297715T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/586—Liposomes, microcapsules or cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Glanulating (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98949090T 1997-10-16 1998-10-14 Teilchen ATE297715T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721901.8A GB9721901D0 (en) 1997-10-16 1997-10-16 Particles
PCT/GB1998/003071 WO1999020252A1 (en) 1997-10-16 1998-10-14 Particles

Publications (1)

Publication Number Publication Date
ATE297715T1 true ATE297715T1 (de) 2005-07-15

Family

ID=10820629

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98949090T ATE297715T1 (de) 1997-10-16 1998-10-14 Teilchen

Country Status (12)

Country Link
US (1) US7723056B1 (de)
EP (1) EP1023047B1 (de)
JP (1) JP2001520185A (de)
AT (1) ATE297715T1 (de)
AU (1) AU742846B2 (de)
CA (1) CA2306972A1 (de)
DE (1) DE69830602T2 (de)
ES (1) ES2245044T3 (de)
GB (1) GB9721901D0 (de)
NO (1) NO20001976L (de)
PT (1) PT1023047E (de)
WO (1) WO1999020252A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU770359B2 (en) 1999-02-26 2004-02-19 Shell Internationale Research Maatschappij B.V. Liner hanger
GB0100196D0 (en) * 2001-01-04 2001-02-14 Anmat Technology Ltd Peptides
EP1269993A1 (de) * 2001-06-21 2003-01-02 Applied NanoSystems B.V. Verabreichung von in Lipidvesikeln verpackten kleinen hydrophilen Molekülen
PT1567641E (pt) 2001-08-24 2012-08-21 Uvic Industry Partnerships Inc Proaerolisina contendo sequência de activação de proteases e métodos de uso para o tratamento do cancro da próstata
JP4692983B2 (ja) * 2004-07-12 2011-06-01 独立行政法人科学技術振興機構 リポソーム封入物質がエンドソームから脱出可能なリポソーム
ES2366380T3 (es) 2005-06-14 2011-10-19 Protox Therapeutics Incorporated Método para el tratamiento o prevención de hiperplasia prostática benigna utilizando proteínas formadoras de poros modificadas.
US20070048383A1 (en) * 2005-08-25 2007-03-01 Helmus Michael N Self-assembled endovascular structures
ES2272178B1 (es) * 2005-09-19 2008-03-16 Daniel Serrano Gil Una composicion para ser administrada a un mamifero o a un ser humano.
WO2007095175A2 (en) * 2006-02-15 2007-08-23 Massachusetts Institute Of Technology Thermo-responsive materials
BRPI0905913A2 (pt) 2008-02-14 2015-08-04 3M Innovative Properties Co "polipeptídeos, composição para detectar um microorganismo alvo e métodos para detectar um microorganismo alvo"
EP2361502A1 (de) * 2010-02-05 2011-08-31 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Aktive antimikrobielle Zusammensetzungen, Beschichtungen und Verfahren zur Kontrolle pathogener Bakterien
GB201200490D0 (en) 2012-01-12 2012-02-22 Univ Bath Wound dressing
US20150065821A1 (en) * 2013-09-05 2015-03-05 Google Inc. Nanoparticle Phoresis
US10492709B2 (en) 2015-11-19 2019-12-03 Verily Life Sciences Llc Magnetic probes for in vivo capture and detection of extracellular vesicles
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342826A (en) * 1980-02-04 1982-08-03 Collaborative Research, Inc. Immunoassay products and methods
US4603044A (en) 1983-01-06 1986-07-29 Technology Unlimited, Inc. Hepatocyte Directed Vesicle delivery system
US4900556A (en) * 1985-04-26 1990-02-13 Massachusetts Institute Of Technology System for delayed and pulsed release of biologically active substances
US5374548A (en) 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
US5047245A (en) * 1985-07-26 1991-09-10 The Liposome Company, Inc. Novel composition for targeting, storing and loading of liposomes
US4885172A (en) * 1985-06-26 1989-12-05 The Liposome Company, Inc. Composition for targeting, storing and loading of liposomes
US4808517A (en) * 1985-12-27 1989-02-28 Wisconsin Alumni Research Foundation Bioassay for toxic substances
IE60901B1 (en) * 1986-08-21 1994-08-24 Vestar Inc Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
US4948590A (en) 1987-06-09 1990-08-14 Yale University Avidin or streptavidin conjugated liposomes
IL86650A0 (en) 1987-06-30 1988-11-30 Biophor Corp Animal derived cells and liposomes,having an antigenic protein incorporated into their membrane
US4829011A (en) * 1987-08-27 1989-05-09 Biotrack, Inc. Agglutination assay
US5108921A (en) 1989-04-03 1992-04-28 Purdue Research Foundation Method for enhanced transmembrane transport of exogenous molecules
US5688488A (en) 1989-04-03 1997-11-18 Purdue Research Foundation Composition and method for tumor imaging
JPH0334920A (ja) * 1989-04-21 1991-02-14 Otsuka Pharmaceut Co Ltd リポソームに結合及至組合わされた生物活性化合物及びそれを含有する医薬
AU6501390A (en) 1989-09-21 1991-04-18 Synergen, Inc. Method for transporting compositions across the blood brain barrier
DE3935257A1 (de) 1989-10-23 1991-04-25 Langhals Heinz Mit antikoerpern verknuepfte liposomen als traeger fuer einen gezielten transport von wirkstoffen und reagenzien - fluoreszenzmarkierung der transportwege und des wirkorts
US5525232A (en) * 1990-03-02 1996-06-11 The Liposome Company, Inc. Method for entrapment of cationic species in lemellar vesicles
US5258284A (en) * 1991-01-22 1993-11-02 University Of Maryland, School Of Medicine Nucleic acid probes specific for pathogenic strains of vibrio vulnificus and method employing the same
WO1993010226A1 (en) * 1991-11-19 1993-05-27 North Carolina State University Immunodiagnostic assay using liposomes carrying labels thereof on outer liposome surface
AU4633893A (en) * 1992-06-17 1994-01-04 University Of Massachusetts Medical Center Liposomal formulations for administering to cancer patients
US5334761A (en) 1992-08-28 1994-08-02 Life Technologies, Inc. Cationic lipids
US5618916A (en) 1993-01-06 1997-04-08 The Jewish Hospital Of St. Louis Purified protein which functions as a mycobacterial receptor for fibronectin
CA2155645A1 (en) * 1993-02-09 1994-08-18 Donald S. Coffey Nuclear matrix proteins
US5455265A (en) * 1993-02-11 1995-10-03 Allergan, Inc. Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
US5552311A (en) 1993-09-14 1996-09-03 University Of Alabama At Birmingham Research Foundation Purine nucleoside phosphorylase gene therapy for human malignancy
US5512294A (en) 1994-08-05 1996-04-30 Li; King C. Targeted polymerized liposome contrast agents
US6132764A (en) * 1994-08-05 2000-10-17 Targesome, Inc. Targeted polymerized liposome diagnostic and treatment agents
US5643599A (en) * 1995-06-07 1997-07-01 President And Fellows Of Harvard College Intracellular delivery of macromolecules
US6344436B1 (en) * 1996-01-08 2002-02-05 Baylor College Of Medicine Lipophilic peptides for macromolecule delivery
US6417326B1 (en) * 1996-04-11 2002-07-09 The University Of British Columbia Fusogenic liposomes
US5776487A (en) * 1996-04-19 1998-07-07 Pasteur Sanofi Diagnostics Liposome reagents for immunoassays
US5780319A (en) * 1996-04-19 1998-07-14 Pasteur Sanofi Diagnostics Immunoassays to detect antiphospholipid antibodies
US6020142A (en) * 1996-10-04 2000-02-01 Millennium Pharmaceuticals, Inc. Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders
CA2276267C (en) * 1996-10-15 2009-12-22 The Liposome Company, Inc. Peptide-lipid conjugates, liposomes and liposomal drug delivery
US6482586B1 (en) * 1996-11-22 2002-11-19 Hospital For Sick Children Research And Development Limited Partnership Hybrid compositions for intracellular targeting
CA2203843C (en) * 1997-04-28 2013-07-23 Her Majesty The Queen, In Right Of Canada, As Represented By The Ministe R Of National Defence Liposome-encapsulated poly iclc
US5994149A (en) * 1997-10-01 1999-11-30 Leonard Bloom Rapid test employing an adhesive slide

Also Published As

Publication number Publication date
EP1023047B1 (de) 2005-06-15
AU9547398A (en) 1999-05-10
US7723056B1 (en) 2010-05-25
CA2306972A1 (en) 1999-04-29
DE69830602D1 (de) 2005-07-21
PT1023047E (pt) 2005-10-31
ES2245044T3 (es) 2005-12-16
NO20001976L (no) 2000-06-15
DE69830602T2 (de) 2006-05-04
EP1023047A1 (de) 2000-08-02
JP2001520185A (ja) 2001-10-30
WO1999020252A1 (en) 1999-04-29
AU742846B2 (en) 2002-01-17
NO20001976D0 (no) 2000-04-14
GB9721901D0 (en) 1997-12-17

Similar Documents

Publication Publication Date Title
DE69830602D1 (de) Teilchen
DE69423109D1 (de) Hochempfindlicher molekular identifikator
MX9806064A (es) Composicion de enzimas para disociacion de tejidos.
AU2209799A (en) Test device, method and system for detection of an analyte
DE68917736D1 (de) System zur magnetischen affinitäts-separation von zellen aus zellkonzentraten.
AU2789492A (en) Method and apparatus for detection of nucleic acid sequences
AU3192889A (en) T cell activation markers
EP0135324A3 (en) Method and means for determination of analytes in a particle-containing medium
AU1226999A (en) High gradient magnetic device and method for cell separation or purification
DE58909780D1 (de) Unter Verwendung von Alkenyl-phosphon- und -phosphinsäureester als Vernetzer hergestellte Hydrogele.
DE69637541D1 (de) System zur Erfassung von Teilchen
AU6215780A (en) Chromogenic compounds and their use as enzyme substrates
DE69826452D1 (de) Stellenspezifische proteinmodifizierung
WO1999025878A3 (en) Methods for modulating and identifying cellular senescence
AU7577496A (en) Membrane for chemical and biosensors
EP0378224A3 (de) Verfahren zum Nachweis von kleinzelligem Carzinom und die Verwendung von Sequenzen, die Acylpeptid-Hydrolase codieren, für diesen zweck
AR001732A1 (es) Celulasa alcalina novedosa y método para producirla
DE69836336D1 (de) Regulation der ausschleusung von proteinen
CY1108126T1 (el) Μεθοδοι ελεγχου διαφοροποιησης και αναπτυξης κυτταρου χρησιμοποιωντας πρωτεϊνη συντηξης και ενα φαρμακο
ATE374369T1 (de) Verfahren zur erkennung von regulatoren des zellzyklus
ATE294189T1 (de) Kristallisation von proteinen
DK1019526T3 (da) Fremgangsmåde til bestemmelse af ionkanalaktivitet af et stof
AU3886697A (en) Sensitive detection of cell surface markers on viable cells
BR9407357A (pt) Novos tripeptideos utilizáveis em terapia cns e imune
Kemper et al. Non-ribosomal incorporation of arginine into a specific protein by a cell-free extract of parathyroid tissue

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1023047

Country of ref document: EP